This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Astrazeneca Ab, Hutchison Medipharma Limited. Active years: 2024.
Company Filing History:
1 out of 1,531 
1 out of 37 
Years Active: 2024
Title: Gareth Paul Howell: Innovator in Pharmaceutical Manufacturing
Introduction
Gareth Paul Howell is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceutical manufacturing, particularly through his innovative methods and formulations. His work has implications for the development of new medications and therapeutic agents.
Latest Patents
Gareth Howell holds a patent for a method related to the manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and its polymorphic forms. This specification generally relates to an improved method for the manufacture of this compound, or pharmaceutically acceptable salts thereof, as well as intermediates useful in the manufacture of such compounds and salts.
Career Highlights
Throughout his career, Gareth has worked with prominent companies in the pharmaceutical industry, including Hutchison Medipharma Limited and AstraZeneca. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.
Collaborations
Gareth has collaborated with various professionals in his field, including Andrew Turner and Wei Yu. These collaborations have fostered innovation and have been instrumental in the success of his projects.
Conclusion
Gareth Paul Howell is a distinguished inventor whose work in pharmaceutical manufacturing has led to valuable advancements in the industry. His patent and collaborations reflect his commitment to innovation and excellence in drug development.